TY  - CHAP
AU  - Donna Molaie
AU  - Phioanh Leia Nghiemphu
ED  - Francesco Signorelli
ED  - Raffaella Messina
Y1  - 2019-11-26
PY  - 2019
T1  - Neurofibromatosis Type 2: Current Trends and Future Directions for Targeted Biologic Therapies
N2  - Neurofibromatosis, one of the most common genetic disorders, is a group of three conditions—Neurofibromatosis 1, Neurofibromatosis 2 and Schwannomatosis—that share some clinical features, such as the presence of cranial and spinal nerve sheet tumors. However, they differ in type of genetic disorder, age of clinical onset, manifestations, management and prognosis. Due to multisystem involvement, a multidisciplinary treatment approach that includes research is ideal. This book provides a systematic, comprehensive and updated outline of Neurofibromatosis. It is a useful reference for clinicians, researchers and students.
BT  - Neurofibromatosis
SP  - Ch. 3
UR  - https://doi.org/10.5772/intechopen.90163
DO  - 10.5772/intechopen.90163
SN  - 978-1-78985-530-2
PB  - IntechOpen
CY  - Rijeka
Y2  - 2024-05-10
ER  -